Robert Fortino, The Leading GLP-1 Weight Loss Doctor in Philadelphia, Known as the Philly Diet Doc The Leading GLP-1 Weight Loss Doctor in Philadelphia, Known as the Philly Diet Doc For over 25 years, residents of Pennsylvania, New Jersey, and Delaware have trusted Dr
Some people experience bloating, stomach pain, or a general feeling of being too full
GLP-1 agonists (glucagon-like peptide-1 agonists) were first developed for type 2 diabetes and are now widely prescribed for weight management
If you experience any suspected adverse reactions to either medication, you can report them through the MHRA Yellow Card scheme (yellowcard.mhra.gov.uk or the Yellow Card app)
These include enhanced fat oxidation, improved insulin sensitivity through GIP-mediated pathways, and potentially greater preservation of lean mass during weight loss
- **Patient Education**: Tips for educating patients on the use of their injection pens and what to expect during treatment
